Drug intelligence / Profile preview

(methylpyridazine piperidine butyloxyphenyl)ethylacetate

Development stage
Unknown
Modality
Small Molecules
01

Overview

(methylpyridazine piperidine butyloxyphenyl)ethylacetate is a synthetic small molecule belonging to the class of benzoic acid esters. Its chemical formula is C23H31N3O3 and it has a molecular weight of approximately 397.5 g/mol[1][2][3]. The compound is also known by code names R80633 and DB08014, and its structure features a methyl-substituted pyridazine ring linked via a piperidine moiety to a butyloxyphenyl group, which is further esterified with an ethyl group. There are no approved therapeutic indications or clinical trial data available for this compound as of the latest updates; it appears to be an experimental molecule with no established mechanism of action or known pharmacological activity in humans[2]. No information on its developer, manufacturer, or primary indication has been published.

Other names
(methylpyridazine piperidine butyloxyphenyl)ethylacetateethyl 4-{4-[1-(6-methylpyridazin-3-yl)piperidin-4-yl]butoxy}benzoateethyl 4-(4-(1-(6-methylpyridazin-3-yl)piperidin-4-yl)butoxy)benzoate

Beyond the preview

Go deeper on (methylpyridazine piperidine butyloxyphenyl)ethylacetate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on (methylpyridazine piperidine butyloxyphenyl)ethylacetate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call